Consistent with our prior observations11, anti-CD40L treatment at tumor implantation did not impact the number of SIY-specific T cells, but significantly decreased the proportion of antigen-specific T cells that express CD103 (Supplementary Fig. S4c). The gene discussed is ITGAE; the disease is neoplasm.